either automatically or manually. Several validation studies reported that AL can identify patients with AHI ≥ 15 with high sensitivity and specificity. Manual scoring of the data produced more accurate results than the automatic analysis. However, only a few reports have evaluated the use of AL, and no studies have evaluated manual versus automatic scoring of the device in Korean patients with OSA.
This study aimed to evaluate the accuracy of automatic and manual scoring of AL compared with standard PSG. We 1) evaluated agreement of respiratory events between the two devices, 2) determined the accuracy of AL in identifying patients with OSA with AHI ≥ 15 or 30, and 3) compared accuracy between automatic and manual scoring of AL.
METHODS

Patients
This retrospective single-center study was performed at Kyung-Hee University Hospital at Gangdong between March 2008 and January 2015. Consecutive patients who were suspected to have OSA according to their symptoms (snoring with or without witnessed apneas and/or somnolence) and who underwent AL for evaluation of OSA and confirmatory standard PSG within a 3-month interval were included. Those who had any therapy during PSG or underwent split-night studies were excluded. This study was approved by the Ethics Committee at Kyung-Hee University Hospital at Gangdong.
Polysomnography
PSG was performed using a digital polygraph system (GrassTelefactor Twin version 2.6; Astro-Med Inc., West Warwick, RI, USA). The data were manually scored according to the American Academy of Sleep Medicine Manual for the Scoring of Sleep and Associated Events, Version 2.0. 10 Apnea was scored if there was a drop of ≥ 90% in the oronasal thermal sensor signal for ≥ 10 seconds. Hypopnea was scored if the peak signal excursions of the nasal pressure sensor dropped by ≥ 30% for ≥ 10 seconds with ≥ 3% oxygen desaturation from the pre-event baseline or with event-associated arousal.
ApneaLink
Signals from the recorder were automatically analyzed based on default settings using AL software (version 9.30; ResMed Corporation, San Diego, CA, USA). The AL default settings for apneas and hypopneas were used as in previous studies.
11 -14 Apnea was defined as a decrease in airflow by 80% of baseline for 10 to 100 seconds, and hypopnea was defined as a decrease in airflow by 50% of baseline for 10 to 100 seconds. The software also provides manual editing, which enables the operator to edit or delete events or to insert new ones. The results of automatic scoring were reviewed and manually corrected by a technologist trained in PSG reading. The AHI from automatic scoring (AL-AHIa) and manual scoring (AL-AHIm) was used for this study.
Statistical Analysis
Values were expressed as the mean ± standard deviation (SD). A Bland-Altman plot, which represents observed differences between paired measurements, was used to assess the agreement between PSG-AHI and AL-AHIa or AL-AHIm. The limits of agreement have been defined as ± 2 SD. The degree of association among the respiratory event variables (AI, HI, and AHI) between PSG and AL (with automatic or manual scoring) was evaluated using the Pearson correlation coefficient (r).
Receiver operating characteristic (ROC) curves were plotted to 
RESULTS
Clinical Features and Demographics
Initially, 98 consecutive patients who underwent AL followed by PSG within 3 months were considered for inclusion. Seven patients whose AL raw data were unavailable and ten patients who had split-night PSG were excluded. Eventually, a total 81 patients were included in the analysis.
Overall, the mean age was 56 ± 10 years; 80% were male, with a mean body mass index (BMI) of 26.3 ± 3.2 kg/m 2 . The mean interval between the AL and PSG studies was 27.7 ± 19.2 days. Patient characteristics and the results of PSG studies are shown in Table 1 .
Agreement of PSG-AHI vs. AL-AHIa and AL-AHIm
PSG-AHI ranged from 0 to 81.8/hour, with a mean value of 24.2 ± 19.4/hour. AL-AHIa and AL-AHIm ranged from 2 to 75/hour and 4 to 72/hour, with a mean of 24.7 ± 15.3/hour and 23.2 ± 14.6/hour, respectively. PSG identified moderate to severe OSA (AHI ≥ 15) in 52 of 81 (64.2%) patients. AL showed moderate to severe OSA in 61 (75.3%) patients with the automatic scoring and 60 (74.1%) patients with the manual scoring. Nine patients with moderate to severe OSA were misclassified as false-negative by AL by either automatic or manual scoring. A Bland-Altman plot of the data showed very good agreement between the PSG-AHI and AL-AHIa or AL-AHIm, with mean difference values of -0.511 and 0.995, respectively (Fig. 1) .
PSG-AHI was significantly correlated with AL-AHIa and AL-AHIm. The AI also showed a significant correlation between PSG and AL-AHIa or AL-AHIm; however, the HI did not (Fig. 2) . tively (Fig. 3) . For moderate OSA, the sensitivity of AL was high, but the specificity was low. For severe OSA, the specificity of AL was high, but the sensitivity was low. Positive and NPV were higher with manual scoring for both moderate and severe OSA ( Table 2) . 
Accuracy of Automatic and Manual
DISCUSSION
This study shows a high level of agreement in the AHI between AL, an unattended type of home sleep test device, and PSG performed within 3 months. AL demonstrated a high level of sensitivity (> 80%) for moderate OSA and a high level of specificity for severe OSA. Manual scoring of the AL data provided more reliability than automatic scoring in identifying both moderate and severe OSA. Our data support the use of AL for screening moderate OSA and emphasize the need for manual correction of its data.
The PSG-AHI and AL-AHI were strongly correlated with each other for both automatic and manual scoring. Agreement in the AHI between AL and PSG has been demonstrated in several previous studies. 9, 11, 15, 16 Our data show that AL can reliably predict actual the AHI in patients with sleep apnea in a real clinical setting. Unlike the AI, which is also highly correlated between PSG and AL, the HI was discordant between the two tests. Because AL uses only a pressure cannula to score hypopnea, respiratory events consisting of a 30-50% drop in nasal pressure with more than 3% desaturation or arousals may not be scored as a hypopnea. Additionally, the pressure cannula tends to misclassify apneas as hypopneas. 17 Therefore, the AHI from AL should be interpreted cautiously in accordance with clinical findings in hypopnea-dominant OSA patients.
AL identified patients with moderate OSA with more than 80% sensitivity. This result is in line with previous studies, as summarized in Table 3 . However, for severe OSA, the sensitivity of AL was less than 50%, which was lower than in previous studies that simultaneously recorded AL and PSG. 11, 12, 15, 16 However, one study that performed PSG within 16 weeks after AL reported a similar sensitivity value to our study. 12 The low sensitivity that we observed for severe OSA may have occurred because we also performed AL and PSG at different time points (within 3 months). The specificity and AUC value of AL in our study were much lower than in previous reports (meaning, more data were false positive), regardless of whether OSA was moderate or severe. This result may also be caused by the different time points of AL and PSG. Lower BMI in our patients may also have caused the difference. Because it is better to "screen in" than to "screen out" cases for screening purposes, AL may be useful in screening patients with moderate OSA who require CPAP therapy.
Diagnostic performance of the manual analysis of AL was superior to the performance of automated scoring, which is in line with previous reports. 8, 12 Compared with automatic scoring methods, manual scoring provided a higher AUC and specificity as well as positive and negative predictive value. Discordance between manual and automatic scoring was prominent in hypopnea events. Additionally, abrupt changes in airflow amplitude, as in movements or sighs, can be misclassified as hypopneas with automatic scoring. Visual inspection of the data can correct such errors and provide more accurate AHI data.
Although this study was the first to determine the usefulness of AL for screening suspected OSA in Korean patients, several limitations should be noted. As this was a retrospective singlecenter study and not all patients with clinically suspected OSA underwent AL and follow-up PSG study, there is a risk of selection bias. We used the AHI from PSG as a reference value; however, in-laboratory PSG performed within 3 months does not 
Conclusion
A single-channel portable monitoring device (AL) identified patients with moderate OSA with high sensitivity. Manual correction of automatic scoring data provided more reliable AHIs for determining both moderate and severe OSA. For patients with symptoms of sleep-disordered breathing, AL can be used as a reliable tool for screening patients with moderate OSA with manual scoring. Those with an AL-AHIm of 15 or more should be further evaluated and considered as CPAP candidates.
